Transgene closes enrolment in Phase II lung cancer trial

Transgene closes enrolment in Phase II lung cancer trial - Drug Development Technology

- May 29, 2019

Transgene closes enrolment in Phase II lung cancer trial Drug Development Technology

Transgene has completed patient enrolment in a Phase II trial of TG4010 in combination with Opdivo plus chemotherapy to treat advanced non-squamous ...

Search This Blog

Lung Cancer

Transgene closes enrolment in Phase II lung cancer trial - Drug Development Technology

Comments

Post a Comment

Popular posts from this blog

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago

Not An Ordinary Cough: Lung Cancer Symptoms That You Might Neglect - International Business Times

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago